 | Up a level |
Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Linde, Louise; Jacobsson, Lennart; Nissen, Michael J; Kristianslund, Eirik Klami; Santos, Maria José; Nordström, Dan; Rotar, Ziga; Gudbjornsson, Bjorn; Onen, Fatos; Codreanu, Catalin; Lindström, Ulf; Möller, Burkhard; Kvien, Tore K; Barcelos, Anabela; Eklund, Kari K; Tom, Matija; Love, Thorvardur Jon; Can, Gercek; ... (2024). Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis - does it depend on the reason for withdrawal from the previous treatment? Joint bone spine, 91(4), p. 105729. Elsevier 10.1016/j.jbspin.2024.105729
Linde, Louise; Georgiadis, Stylianos; Ørnbjerg, Lykke M; Rasmussen, Simon H; Michelsen, Brigitte; Askling, Johan; Di Giuseppe, Daniela; Wallman, Johan K; Závada, Jakub; Pavelka, Karel; Bernardes, Miguel; Matos, Carolina O; Glintborg, Bente; Loft, Anne Gitte; Nordström, Dan; Kuusalo, Laura; Möller, Burkhard; Nissen, Michael J; Codreanu, Catalin; Mogosan, Corina; ... (2024). Comparing DAPSA, DAPSA28 and DAS28-CRP in patients with psoriatic arthritis initiating a first TNF-inhibitor across nine European countries. (In Press). Arthritis care & research Wiley 10.1002/acr.25396
Thomas, Matthew L; Shaddick, Gavin; Charlton, Rachel; Cavill, Charlotte; Holland, Richard; Iannone, Florenzo; Lapadula, Giovanni; Lopriore, Simona; Závada, Jakub; Uher, Michal; Pavelka, Karel; Szczuková, Lenka; Sidiropoulos, Prodromos; Flouri, Irini; Drosos, Alexandros; Möller, Burkhard; Nissen, Michael J; Müller, Rüdiger B; Scherer, Almut; McHugh, Neil; ... (2021). Tumor Necrosis Factor Inhibitor Monotherapy Versus Combination Therapy for the Treatment of Psoriatic Arthritis: Combined Analysis of European Biologics Databases. The journal of rheumatology, 48(1), pp. 48-57. The Journal of Rheumatology Publishing Company Limited 10.3899/jrheum.190815
Brahe, Cecilie Heegaard; Ørnbjerg, Lykke Midtbøll; Jacobsson, Lennart; Nissen, Michael J; Kristianslund, Eirik Klami; Mann, Herman; Santos, Maria José; Reino, Juan Gómez; Nordström, Dan; Rotar, Ziga; Gudbjornsson, Bjorn; Onen, Fatos; Codreanu, Catalin; Lindström, Ulf; Möller, Burkhard; Kvien, Tore K; Pavelka, Karel; Barcelos, Anabela; Sánchez-Piedra, Carlos; Eklund, Kari K; ... (2020). Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment-results from 12 countries in EuroSpA. Rheumatology, 59(7), pp. 1640-1650. Oxford University Press 10.1093/rheumatology/kez427
Peterfy, Charles; Emery, Paul; Tak, Paul P; Østergaard, Mikkel; DiCarlo, Julie; Otsa, Kati; Navarro Sarabia, Federico; Pavelka, Karel; Bagnard, Marie-Agnes; Gylvin, Lykke Hinsch; Bernasconi, Corrado Angelo; Gabriele, Annarita (2016). MRI assessment of suppression of structural damage in patients with rheumatoid arthritis receiving rituximab: results from the randomised, placebo-controlled, double-blind RA-SCORE study. Annals of the rheumatic diseases, 75(1), pp. 170-177. BMJ Publishing Group 10.1136/annrheumdis-2014-206015
Bykerk, Vivian P; Östör, Andrew J K; Alvaro-Gracia, José; Pavelka, Karel; Román Ivorra, José Andrés; Graninger, Winfried; Bensen, William; Nurmohamed, Michael T; Krause, Andreas; Bernasconi, Corrado Angelo; Aassi, Maher; Sibilia, Jean (2015). Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice. Clinical rheumatology, 34(3), pp. 563-571. Springer 10.1007/s10067-014-2857-y
